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June Supplement 201166S Abstractslinked, porcine pericardial patch (dCELL, Tissue
Regenix, UK).
Methods: Informed consent was obtained. Elective
FEA with dCELL patch closure was performed using stan-
dard technique. Postoperative examination and Doppler
ultrasound was performed at 1, 3, 6, and 12 months.
Results: 21 patients participated; all were examined
at 6 months and 18 were followed at 12 months (86%).
64% were active smokers; 27% had diabetes; 55% had
previous vascular procedures. Mean time to hemostasis
was 3.5  2.1 min. Handling characteristics were con-
sidered excellent. There was one wound hemorrhage
requiring reoperation, not due to the patch. There was
one superficial wound infection not related to the patch.
There was one early asymptomatic occlusion (22 d)
associated with an occluded profunda. In mid-term fol-
lowup, 4 patients developed non-flow-limiting neointi-
mal hyperplasia 2mm; mean neointima was 0.78mm.
Mean mid-patch PSV was 93.3 cm/s at 12 months which
was similar to 90.18 cm/s at 1 month; there was no
change in mid-patch neointima at 1 and 6 months (di-
ameter 9.22 0.22 mm vs. 8.99 1.31 mm, p0.583).
No aneurysmal dilation occurred (mean internal diame-
ter 8.12 cm vs. 8.39 cm proximal, p0.71). In 56% it was
impossible to distinguish the patch wall due to remodel-
ling. There were no pseudoaneurysms.
Conclusions: dCELL porcine pericardial patches are
safe and effective for patch angioplasty, with minimal reste-
nosis and excellent tissue incorporation. dCELL patches
may be a platform for next-generation tissue-engineered
closure devices.
Author Disclosures: G. Acsády: Nothing to disclose; A.
Dardik: Nothing to disclose; I. Mogán: Nothing to dis-
close; L. Mátyás: Nothing to disclose; P. van Eijkelen-
burg: Nothing to disclose.
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Outcomes of Below-Knee Bypasses in African Origin
Patients for Critical Limb Ischemia: The French West
Indies Experience
Sherif Attia1, Michel Deneuville2. 1Pointe à Pitre Univer-
sity frensh center, Pointe à pitre cedex, Guadeloupe;
2Pointe à pitre university center, pointe à pitre cedex,
Guadeloupe
Objectives: Prior studies have documented racial and
ethnic disparities in rates of graft function and limb salvage
in the United States. We analyze the outcomes of below-
knee bypasses in the African origin (AO) patients in the
French West Indie.
Methods: This was a retrospective, comparative cohort
study of male and female of AO patients who had undergone
autogenous below-knee bypass surgery in a single center.
Results: One hundred seventeen below-knee by-
passes were performed for critical lower limb ischemia.
Compared with the male cohort, the female group were
significantly older (median age 77.4, 51-92 years, p.009) and presented with tissue loss CLI (84% VS75%
n male group, P.24).The great saphenous vein was
sed in both groups and limb salvage was the indication
f bypass. The 30day graft failure was significantly worse
n the female (24% VS12% in the male group, P.09).
he 2-year primary patency rate was also significantly
orse in the female patients 44% VS60% in the male
roup, P.01). The 2-year LS rate was significantly
orse 58% in the female group VS 73% in the male group
P0.012). With the Cox proportional hazard mode,
ignificant risk factors associated with primary graft fail-
re and LS as female sex, renal failure, tibial bypasses and
ein diameter.
Conclusions: In Guadeloupe, the AO race and female
ender are risk factors for adverse outcomes after vein bypass
urgery for limb salvage. Graft failure and limb loss are com-
on events in AO race, with women being a particular high
isk group.
uthor Disclosures: S. Attia: Nothing to disclose; M.
eneuville: Nothing to disclose.
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ate of Amputees following Below-Knee Amputation:
arly and Mid-Term Results
ulius Poon1, Sebastian Ko1, Musaad al-Ghamdi1, Heather
nderwood2, ElliottWeiss2, YorkN.Hsiang1. 1Vancouver
eneral Hospital, Vancouver, BC, Canada; 2GF Strong
nd Holy Family Hospitals, Vancouver, BC, Canada
Objectives: The objective of this study was to deter-
ine the outcomes of patients undergoing below-knee
mputation (BKA) for critical limb ischemia.
Methods: A retrospective review of all patients under-
oing BKA by the Vascular Surgery service of a tertiary care
eaching hospital from Jan 1, 2006 to Dec 31, 2007 was
Fig1. Overall primary graft patency by sex. Time (days).erformed. Demographic and clinical data was collected
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Volume 53, Number 17S Abstracts 67Sand analyzed. Up to 2-year follow up was determined by
contacting patients or physicians working at rehabilitation
hospitals.
Results: Over this two-year period, 60 patients under-
went BKA (45 male, 15 female), with one patient having
bilateral BKAs The average age was 67 years (range 38-91).
Preoperatively, 33/61 were not able to walk. The indica-
tions for surgery was entirely for sepsis or ischemia, (61/61,
100%). Furthermore, 36/61 (58%) of the patients had
failure of a previous revascularization or more distal ampu-
tation, and 5/61 (8%) required an amputation despite a
patent bypass graft. Major co-morbidities were diabetes
(49/61, 80%) and chronic renal failure (25/61, 41%).
There were 4 perioperative deaths (6%). Seventeen (28%)
wound complications occurred, of which 14 (23%) re-
quired revision. The average length of stay before transfer
to a rehab facility was 25.6 days. During a follow up period
of two years, 25 patients (42%) died. Twelve patients were
lost to follow up. The average time to final prosthesis was
4.8 months. At one year post BKA, 33/35 (94%) patients
who were alive, were walking with their prosthesis, and
2/61 (3%) could not walk because of either a poorly fitting
prosthesis or poor wound healing.
Conclusions: When BKA is required for sepsis or isch-
emia; the vast majority of patients can expect to survive the
procedure. However, amputation revision is commonly
needed. The two-year survival is poor. Nonetheless, for
patients who tolerate amputation and survive at least two
years, ambulation with a walking prosthesis was seen in the
vast majority.
Author Disclosures: M. al-Ghamdi: Nothing to dis-
close; Y. N. Hsiang: Nothing to disclose; S. Ko: Noth-
ing to disclose; J. Poon: Nothing to disclose; H. Un-
derwood: Nothing to disclose; E. Weiss: Nothing to
disclose.
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The Influence of Gender on Infrageniculate Interven-
tions
Andrew Tye, Ageliki G. Vouyouka, Rami O. Tadros, Con-
stantinos T. Spyris, Sung yup Kim, Victoria J. Teodorescu,
Windsor Ting, Sharif H. Ellozy, Michael L. Marin, Peter L.
Faries. Vascular Surgery, The Mount Sinai Medical Center,
New York, NY
Objectives: This study assesses the influence of gender
on infrageniculate peripheral arterial disease (PAD) treated
percutaneously.
Methods: Sixty-one patients (30males and 31 females)
requiring infrageniculate interventions were studied. Males
and females were compared over 24 months. Statistical
analysis was conducted with SPSS software (SPSS Inc.
Chicago, IL).
Results: Females presented for treatment of infra-
geniculate PAD at a later age than males (75.6 vs. 67.5
years, p0.008) and were more likely to have co-morbid UOPD (p0.023). There were no differences in other
o-morbidities, rates of tissue loss or rest pain at presen-
ation, disease distribution, primary procedures per-
ormed, peri-procedural complications, lengths of stay
LOS), primary and secondary patency, limb salvage, or
ortality. However, males were more likely to undergo
imultaneous treatment of popliteal and tibial lesions
28.1% vs. 6.1%, p0.019) and were more likely to
equire a bypass after failed primary interventions (10.5%
s. 0.0%, p0.044).
Conclusions: The presentation and disease distribu-
ion of PAD are comparable among males and females.
elow-the-knee interventions are safe and effective in both
enders with similar overall outcomes. However, males
resent for treatment of infrageniculate PAD at an earlier
ge and are more likely to require a bypass after failed
rimary interventions.
uthor Disclosures: S. H. Ellozy: Nothing to disclose;
. L. Faries: Nothing to disclose; S. Kim: Nothing to
isclose; M. L. Marin: Nothing to disclose; C. T.
pyris: Nothing to disclose; R. O. Tadros: Nothing to
isclose; V. J. Teodorescu: Nothing to disclose; W.
ing: Nothing to disclose; A. Tye: Nothing to disclose;
. G. Vouyouka: Nothing to disclose.
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ikel Sadek, Lowell S. Kabnick, Todd Berland, Cara Cha-
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an, Glenn R. Jacobowitz, Patrick J. Lamparello, Mark A.
delman. Surgery, Division of Vascular Surgery, New York
niversity Medical Center, New York, NY
